EE200200350A - Ühend ja meetod valu raviks - Google Patents

Ühend ja meetod valu raviks

Info

Publication number
EE200200350A
EE200200350A EEP200200350A EEP200200350A EE200200350A EE 200200350 A EE200200350 A EE 200200350A EE P200200350 A EEP200200350 A EE P200200350A EE P200200350 A EEP200200350 A EE P200200350A EE 200200350 A EE200200350 A EE 200200350A
Authority
EE
Estonia
Prior art keywords
compound
treating pain
pain
treating
Prior art date
Application number
EEP200200350A
Other languages
English (en)
Estonian (et)
Inventor
Michael Bare Thomas
Gordon Brown Dean
Murphy Megan
Ann Urbanek Rebecca
Xiao Wenhua
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200350A publication Critical patent/EE200200350A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/503Pyridazines; Hydrogenated pyridazines spiro-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541Non-condensed thiazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200200350A 1999-12-23 2000-12-19 Ühend ja meetod valu raviks EE200200350A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US23678300P 2000-09-29 2000-09-29
PCT/SE2000/002611 WO2001047927A1 (fr) 1999-12-23 2000-12-19 Compose et procede de traitement de la douleur

Publications (1)

Publication Number Publication Date
EE200200350A true EE200200350A (et) 2003-10-15

Family

ID=26867555

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200350A EE200200350A (et) 1999-12-23 2000-12-19 Ühend ja meetod valu raviks

Country Status (29)

Country Link
EP (1) EP1244662B1 (fr)
JP (1) JP2003519149A (fr)
KR (1) KR20020062369A (fr)
CN (1) CN1188413C (fr)
AR (1) AR027037A1 (fr)
AT (1) ATE294177T1 (fr)
AU (1) AU779703B2 (fr)
BG (1) BG106831A (fr)
BR (1) BR0016654A (fr)
CA (1) CA2394888A1 (fr)
CO (1) CO5271689A1 (fr)
CZ (1) CZ296877B6 (fr)
DE (1) DE60019807T2 (fr)
DK (1) DK1244662T3 (fr)
EE (1) EE200200350A (fr)
ES (1) ES2239632T3 (fr)
HK (1) HK1048811B (fr)
HU (1) HUP0300313A3 (fr)
IL (1) IL150208A0 (fr)
IS (1) IS6427A (fr)
MX (1) MXPA02006155A (fr)
MY (1) MY133596A (fr)
NO (1) NO20022984L (fr)
NZ (1) NZ519390A (fr)
PL (1) PL356664A1 (fr)
PT (1) PT1244662E (fr)
RU (1) RU2234507C2 (fr)
SK (1) SK8792002A3 (fr)
WO (1) WO2001047927A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0403172D0 (sv) * 2004-12-23 2004-12-23 Astrazeneca Ab Manufacturing process
US20060280791A1 (en) * 2005-04-08 2006-12-14 Ju Tzuchi R Pharmaceutical formulations
JP5790533B2 (ja) * 2012-02-14 2015-10-07 住友化学株式会社 フェニルヒドラジン−β−カルボキシレート化合物の精製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420590D0 (en) * 1993-10-22 1994-11-30 Zeneca Ltd Pyridazino quinoline compounds

Also Published As

Publication number Publication date
WO2001047927A1 (fr) 2001-07-05
IL150208A0 (en) 2002-12-01
PT1244662E (pt) 2005-07-29
JP2003519149A (ja) 2003-06-17
PL356664A1 (en) 2004-06-28
RU2234507C2 (ru) 2004-08-20
CZ20022177A3 (cs) 2002-11-13
DK1244662T3 (da) 2005-07-11
HUP0300313A3 (en) 2007-05-02
NZ519390A (en) 2003-07-25
EP1244662A1 (fr) 2002-10-02
SK8792002A3 (en) 2003-05-02
HK1048811A1 (en) 2003-04-17
CA2394888A1 (fr) 2001-07-05
ES2239632T3 (es) 2005-10-01
BG106831A (en) 2003-03-31
CN1411459A (zh) 2003-04-16
NO20022984L (no) 2002-08-20
NO20022984D0 (no) 2002-06-20
IS6427A (is) 2002-06-19
CN1188413C (zh) 2005-02-09
HUP0300313A2 (hu) 2003-06-28
BR0016654A (pt) 2002-09-03
AR027037A1 (es) 2003-03-12
AU2420301A (en) 2001-07-09
MY133596A (en) 2007-11-30
KR20020062369A (ko) 2002-07-25
CZ296877B6 (cs) 2006-07-12
DE60019807D1 (de) 2005-06-02
HK1048811B (zh) 2005-09-30
AU779703B2 (en) 2005-02-10
EP1244662B1 (fr) 2005-04-27
ATE294177T1 (de) 2005-05-15
CO5271689A1 (es) 2003-04-30
MXPA02006155A (es) 2002-12-05
DE60019807T2 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
FI20000863A0 (fi) Uusi hoitomenetelmä
EE200200242A (et) Meetod suhkurtõve raviks
ID30025A (id) Metode perlakuan tekstil
HK1047432A1 (en) Hemisynthetic method and new compounds
DE60031119D1 (de) Richtbohrvorrichtung und -verfahren
EP1200086A4 (fr) Procedes therapeutiques ou prophylactiques de la douleur et de l'anxiete
ID30339A (id) Metode pengobatan baru
IL154225A0 (en) Method for treating ammonia-containing organic waste
ID19570A (id) Metode merawat tanaman kotiledonous
DE69920224D1 (de) Harnstoffderivate zur Schmerzbekämpfung
EE200200350A (et) Ühend ja meetod valu raviks
EE200100710A (et) Meetod ja seade graanulite valmistamiseks
FI991267A0 (fi) Menetelmä paperirainan viemiseksi ja paperirainan vientilaitteisto
EE200000074A (et) Meetod ja seade jäätmete töötlemiseks
ID16924A (id) Metode perlakuan poliolefin
DE69936533D1 (de) Neue behandlungsmethode
FI20001913A0 (fi) Menetelmä ja järjestely häiriön vähentämiseksi
ID26641A (id) Metoda pengobatan
SE9802791D0 (sv) Behandlingsmetod
FI19992288A (fi) Menetelmä ja laitteisto kasvun tehostamiseksi
FI990554A (fi) Monitorointimenetelmä ja monitorointijärjestely
FI19992634A (fi) Menetelmä kanavan muodostamiseksi ja kanava
FI20002229A0 (fi) Menetelmä selkäkivun hoitamiseksi
FI20001043A (fi) Käärintäpakkausmenetelmä ja käärintäpakkauskone
FI990341A0 (fi) Menetelmä ja laitteisto ratapölkyn asentamiseksi